29945 Osseointegrated Orbital Reconstruction: A 24-Year Experience

Monday, September 26, 2016: 11:35 AM
Joshua J DeSerres, MD , Plastic Surgery, University of Alberta, Edmonton, AB, Canada
Curtis Budden, MD , Plastic Surgery, University of Alberta, Edmonton, AB, Canada
Johan Wolfaardt, BDS, MDent, PhD , Otolaryngology-Head and Neck Surgery, University of Alberta, Edmonton, AB, Canada
Lindsay McHutchion, BSc, MS , Institute for Reconstructive Sciences in Medicine, Edmonton, AB, Canada
Akhila Regunathan, BFA, MS , Institute for Reconstructive Sciences in Medicine, Edmonton, AB, Canada
Gordon Wilkes, MD , Plastic Surgery, University of Alberta, Edmonton, AB, Canada

Purpose: Osseointegrated implants have been used for craniofacial prosthetic reconstruction since 1979.1 Since then, they have been used for prosthetic rehabilitation of a variety of facial defects, including the orbit.2The authors sought to review long-term results of osseointegrated orbital reconstruction at the Institute for Reconstructive Sciences in Medicine (iRSM).

Methods: 26 patients have undergone osseointegrated orbital prosthetic (OOP) reconstruction at the iRSM since 1990. A retrospective chart review was performed to determine demographics, skin reactions and implant failures. 7 patients are deceased, therefore a satisfaction survey was sent to the remaining 19 patients. Patient satisfaction was assessed through a questionnaire used in previous osseointegration studies.3 A logistic regression analysis was performed to assess the relationship between smoking, age, gender, and prior radiation treatment with the occurrence of a skin reaction and implant failure. Skin reactions were assessed using the Modified Holgers Classification.4A Chi-square test was used to assess the relationship between implant position within the orbit and development of a skin reaction or implant failure.

Results: The most common indication for reconstruction was oncologic, followed by traumatic and congenital. Patients received an average of 5.8 implants during the course of treatment. The average follow-up time was 10.6 years with a range of 6 months to 24 years. A statistically significant correlation was found between skin reaction and age (p=0.022), with younger patients more likely to develop a reaction. When assessing implant failure, no variables in our model were significant for predicting failure of osseointegration. Overall, there were 39 failures out of 155 osseointegrated implants, for a success rate of 74.8%. There was no relationship between skin reaction or implant failure compared to implant position within the orbit. Survey responses were received from 11 of 19 patients, for a response rate of 58%. 82% of patients rated their prosthesis as comfortable and 91% reported good self-confidence with the prosthesis. 91% of patients were overall satisfied with their prosthesis, despite 55% of patients who felt that they had a skin reaction.

Conclusions: There are minimal contraindications for consideration of OOP reconstruction. Patients find the prosthesis comfortable to wear, report increased self-confidence and are happy with their choice to have undergone reconstruction. Prosthetic reconstruction using osseointegrated implants is a good option for reconstruction of the orbit.